A prostate-cancer treatment decision depends on the exact pathology, disease extent, risk profile, symptoms, prior therapy and patient priorities. International patients should seek an individualized specialist review rather than choosing a procedure from a marketing package before their records are assessed.
Multidisciplinary treatment planning
The NCT Heidelberg Prostate Cancer Center describes interdisciplinary development of diagnostic and treatment concepts involving urology, oncology, radiotherapy, nuclear medicine, pathology and diagnostic/interventional radiology. This type of structure is important when more than one reasonable treatment pathway may exist.
Records that can matter for a second opinion
The reviewing center may need more than a diagnosis name. Prepare the underlying evidence so specialists can understand the disease accurately.
- Pathology report and, if requested, slides or tissue blocks
- PSA history and relevant laboratory results
- MRI, PSMA PET/CT, CT, bone imaging or other studies when performed
- Biopsy and surgical reports
- Details of prior radiation, hormone therapy or systemic treatment
- Current symptoms, medicines and major medical conditions
How to evaluate a cancer center in Germany
A useful starting point is whether the center has transparent disease-specific certification and an interdisciplinary treatment structure. The German Cancer Society (DKG) publishes certified cancer centers through OncoMap. Certification is not a guarantee of a particular outcome, but it gives patients a verifiable quality framework instead of relying on paid 'best hospital' lists.
- Check disease-specific certification and its current status
- Confirm that the relevant specialties participate in multidisciplinary review
- Ask whether your case can be reviewed before travel
- Verify the official international-patient contact route
- Request an individualized treatment and cost estimate before booking travel
Avoid choosing treatment by technology alone
Robotic surgery, radiation techniques, nuclear-medicine procedures and systemic therapies can all be important in selected settings, but the presence of a technology does not establish that it is the right option for a particular patient. Ask the center to explain why its proposed strategy fits the documented stage and risk profile.
Planning continuity of care
Prostate-cancer care can extend well beyond a single hospital stay. International patients should ask which follow-up tests can be performed at home, who will interpret them, and how medication or subsequent treatment will be coordinated after returning from Germany.
Sources and review
This guide was last source-reviewed on 2026-08-29.
- Prostate Cancer Center Heidelberg — National Center for Tumor Diseases Heidelberg ↗
- Tumor Board — National Center for Tumor Diseases Heidelberg ↗
- German Cancer Society certification system — Deutsche Krebsgesellschaft ↗
- International Patients – Medical International Office — Heidelberg University Hospital ↗